At IDT Biologika, we are an international leader in the field of biotechnology, a key global technology for the 21st century. Our 95-year tradition of manufacturing vaccines and pharmaceuticals motivates and obligates us to continue our work in improving the health of humans and animals, now and going forward. Today, our company ranks among the top echelon of innovative high-tech life science companies, delivering a consistent level of quality in the standardized production of biopharmaceuticals. We have achieved this position through our commitment to employing highly qualified staff, using state-of-the-art production technologies, and strongly investing in research and development.
Award-winning innovation and quality — IDT focuses on contract manufacturing and animal health. IDT Biologika has received international accolades for the development and manufacturing of new vaccines, as well as its own trail-blazing products in animal health.
Plans to Build Out New, State-of-the-Art Vaccine Manufacturing Hub in Ontario more info
After two years of construction, IDT Biologika is celebrating the opening of its new research and development building at its Riems site in Greifswald. more info
IDT Biologika receives Life Science Leader’s 2017 CMO Leadership Award in multiple categories more info
IDT Biologika Establishes Animal Health Americas Business Unit more info
RT @IMG_ST: #Erfolgsdosis: Impfstoffe der @idtbiologika im Kampf gegen Epidemien & Krankheiten 🌍 im Einsatz. #Impulsmagazin https://t.co/1… more info
RT @BusinessWireCA: IDT Biologika (@idtbiologika) Animal Health Acquires Facility in Canada to Expand Investment in Americas https://t.co/u… more info
RT @MDTechCouncil: Meeting with #MTCMEMBER @idtbiologika #bio17 https://t.co/W7cCY4X5u7 more info